Mate Act Module
This activity will provide comprehensive and up-to-date information regarding the most recent and relevant laws and clinical practice guidelines regarding the safe and effective management and treatment of pain, including opioid and other substance use disorders. The 8-course series will yield practical guidance for prescribing clinicians who manage patients with pain and/or substance use disorders, including detailed information on appropriate treatment selection and management, risk mitigation strategies, and implementation of diversion and surveillance tools for controlled substances. Completion of this activity in full will satisfy the Drug Enforcement Administration (DEA) 8-hour content training requirement for The Medication Access and Training Expansion (MATE) Act.
TARGET AUDIENCE
This activity is designed for All Drug Enforcement Administration (DEA)-registered practitioners who treat patients with opioid or other substance use disorders, including: physicians, nurse practitioners, physician assistants, and dentists..
LEARNING OBJECTIVES
Upon completion of the educational activity, participants will be able to:
Distinguish appropriate actions for prescribers and dispensers related to the federal laws regarding prescription practices for controlled substances via in person and by way of telemedicine settings.
· Explain the appropriate use for and application of opioids and non-opioids in clinical practice, including initiation, continuation/discontinuation, forced opioid tapers, and dose escalation.
· Identify appropriate areas of clinical assessment and evaluation of treatment failure, including how to adequately analyze risks and benefits of specific dosing regimens.
· Integrate workflows that foster responsible opioid prescribing practices, incorporate appropriate risk mitigation strategies and improve the informed consent process between clinicians and patients.
· Outline best practices regarding the implementation of tools for diversion and surveillance of controlled substances.